human cell-based test system that maps important processes of human brain development and thus the allows for non-animal testing of chemicals
Dntox has raised €1.5M across 1 funding round from 5 investors, most recently a round in Jun 2023. Based in Dusseldorf, Germany; active in Healthtech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-06-14 | Other | €1.5M |
| AQAL Capital ,Barbara Korte-Sturm,Bool Capital,High-Tech Gründerfonds (HTGF),Nikolaus Sturm |
| View deal → |
